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Abstract
There are hundreds of viruses that infect different human organs and cause diseases. Some fatal
emerging viral infections have become serious public health issues worldwide. Early diagnosis and
subsequent treatment are therefore essential for fighting viral infections. Current diagnostic
techniques frequently employ polymerase chain reaction (PCR)-based methods to quickly detect
the pathogenic viruses and establish the etiology of the disease or illness. However, the fast PCR
method suffers from many drawbacks such as a high false-positive rate and the ability to detect only
one or a few gene targets at a time. Microarray technology solves the problems of the PCR
limitations and can be effectively applied to all fields of molecular medicine. Recently, a report in
Retrovirology described a multi-virus DNA array that contains more than 250 open reading frames
from eight human viruses including human immunodeficiency virus type 1. This array can be used
to detect multiple viral co-infections in cells and in vivo. Another benefit of this kind of multi-virus
array is in studying promoter activity and viral gene expression and correlating such readouts with
the progression of disease and reactivation of latent infections. Thus, the virus DNA-chip
development reported in Retrovirology is an important advance in diagnostic application which could
be a potent clinical tool for characterizing viral co-infections in AIDS as well as other patients.
Microarray technology has been proven to be a powerful
tool with great potential for biological and medical uses.
In this technique, recombinant DNA fragments or synthe-
sized oligonucleotides affixed on the surface of glass slides
or nylon membranes are used for detecting complemen-
tary nucleic acid sequences (frequently representing a few
hundred to >10,000 genes/expressed sequence tags) as
well as for genotyping microorganisms and for profiling
the gene-expression patterns in cells from higher organ-
isms [1].
A new report by Ghedin, et al. [2] in Retrovirology describes
the successful use of a multi-virus array (termed multivi-
rus-chip) to detect multiple viral co-infections in cultured
cells as well as to study viral gene expression and pro-
moter activities (Figure 1). Ghedin's multivirus-chip con-
tains genes from eight human viruses including human
immunodeficiency virus type 1 (HIV-1). Conceptually,
this chip can be used to detect viral co-infections in AIDS
patients who are frequently rendered susceptible to addi-
tional opportunistic infections. In developing their multi-
virus-chip, Ghedin, et al. tested more than 250 ORFs from
HIV-1, human T cell leukemia virus types 1 (HTLV-1) and
2 (HTLV-2), hepatitis C virus (HCV), Epstein-Barr virus
(EBV), human herpesvirus 6A (HHV6A) and 6B
(HHV6B), and Kaposi's sarcoma-associated herpesvirus
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(KSHV) which were PCR-amplified and spotted on glass
slides. They then hybridized their slides with Cy3- or Cy5-
labeled genomic DNA or cDNAs derived from various
virus-infected cells. Their multivirus-chip was found to be
highly specific and sensitive for detecting different viral
genomic sequences in cell lines. Moreover, the chip could
also detect the effect of various drugs on viral gene expres-
sion. In such instance, cell lines latently infected with
HIV-1 and KSHV were used to generate profiles of viral
gene expression in the presence of cyclin-dependent
Schematic drawing of the multivirus-chip that possesses multiple functions Figure 1
Schematic drawing of the multivirus-chip that possesses multiple functions. The multi-virus array used in the study 
conducted by Ghedin, et al. contains more than 250 DNA spots derived from PCR amplification of ORFs from eight human 
pathogenic viruses. These viruses include HIV-1, HTLV-1, HTLV-2, EBV, HHV-6A, HHV-6B, KSHV, and HCV. Depending on 
how the DNA targets are prepared, the multivirus-chip can be simultaneously used to detect viral genomic sequences, profile 
viral gene expression patterns, and investigate the relationship between cellular chromatin structure and viral gene transcrip-
tion. Therefore, this multi-purpose DNA array is functionally versatile and would be very useful in both clinical diagnoses and 
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kinase inhibitor (CKI), Roscovitine, which was applied to
cells to suppress the reactivation of latently infected
viruses.
Ghedin, et al. [2] also studied the role of cellular chroma-
tin structure on viral gene expression using their multivi-
rus-chip. They employed the chromatin
immunoprecipitation technique (ChIP) [3] to isolate cel-
lular DNA fragments that were bound to phosphorylated
histone H3 (P-H3). These DNA fragments were hybrid-
ized to the viral ORFs contained on the multivirus-chip to
investigate the role of phospho-H3 on viral gene expres-
sion. They showed that whether transcriptionally active or
silent the chromatin state played a role in regulating the
expression of KSHV genes under the different cellular
context.
Current routine clinical diagnostics employ PCR, South-
ern blotting, Northern blotting, DNA sequencing and
microarray hybridization to detect and characterize genes
of interest in biomedicine. PCR is generally regarded as
the most sensitive diagnostic method. However, Iyer, et al.
[4] have shown that the sensitivity of cDNA-chip hybridi-
zation is comparable to that of TaqMan-driven quantita-
tive PCR assay, and that the microarray hybridization
technique is less likely to be complicated by high false
positive rates due to carry-over contaminations. Further-
more, using microarrays, the viral gene transcripts in
infected cells can be easily detected by hybridization with-
out any prior amplification steps, and the microarray
technique requires much less experimental material when
compared to Southern or Northern blotting and can pro-
vide high sensitivity in the setting of large throughput.
In view of the above, the multivirus-chip described in Ret-
rovirology [2] holds several advantages over other more
commonly used techniques (e.g. PCR, DNA sequencing)
for the diagnosis of viral infections. First, this chip pro-
vides a more accurate diagnosis of viral infection by
simultaneously evaluating the transcription of all viral
genes, and can use such cumulative data to correlate infec-
tion with clinical disease manifestations. Second, the high
throughput and flexible synthesis nature of DNA microar-
ray construction can allow scientists to tailor-make and
rapidly alter arrays to match evolving emergence of new
pathogens. The SARS genome chip made by the US
NIAID, NIH is a good example [5] of how diagnostic
arrays can be developed quickly and be used in a timely
manner.
Finally, the most novel application described by Ghedin,
et al. is their use of microarrays to correlate the cellular
"histone code" [6] with the promoter activity of KSHV.
Usually the transcription of a gene located on chromo-
somal DNA is influenced not only by the cis-acting ele-
ments (or DNA-binding motifs), but also by the structure
of chromatin. The latter can be vary depending on the
post-translational modifications of histone proteins.
Methylation, acetylation, and/or phosphorylation of cer-
tain amino acid residues at the amino terminal "tails" of
histone H3 and/or H4 can indeed influence chromatin
structure. Thus accumulating evidence has shown that
chromatin-associated proteins and their modifications
play vital roles in many physiological processes such as
growth, differentiation, and development in mammals,
plants and fungi [6,7]. Many studies have used DNA array
technology to investigate viral gene expression or to geno-
type viral isolates; however, none has used this technique
to study the influence of cellular chromatin structure on
viral gene expression [1]. Ghedin, et al. [2] demonstrated
that only DNA fragments derived from ChIP of latent
BCBL-1 cell genomic DNA captured using phospho-H3
antibody bound specifically to the KSHV ORF on the mul-
tivirus-chip. This result suggests that latent KSHV genome
in BCBL-1 cells is packed into a nucleosomal structure and
that histone H3 proteins near the viral promoter can be
phosphorylated at serines to make the DNA at the pro-
moter region less tightly packed with histones and more
easily accessible to transcription factors.
In conclusion, the multivirus-chip improvements devel-
oped by Ghedin, et al. [2] provide versatile clinical and
basic uses. In the near future, such chips are likely to be
used to detect viral co-infections in many different clinical
settings.
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